Cytokinetics, Incorporated (CYTK) vs Hims & Hers Health, Inc. (HIMS)
A side-by-side comparison of Cytokinetics, Incorporated and Hims & Hers Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CYTK
Cytokinetics, Incorporated
$61.30HealthcareDelayed quote: Oct 6, 2026, 2:50 PM EDT
HIMS
Hims & Hers Health, Inc.
$29.23HealthcareDelayed quote: Oct 6, 2026, 2:50 PM EDT
Total return — CYTK vs HIMS
growth of $100 · dividends reinvested · last 7yCYTK +406.1% (+26.1%/yr)HIMS +202.8% (+17.1%/yr)CYTK compounded faster over this window
CYTK HIMS
CYTK vs HIMS: by the numbers
- •CYTK is the larger company ($7.63B vs $6.52B market cap).
- •Both run net losses; HIMS's is the smaller (-5.51% vs -1259.87% net margin).
- •HIMS grew revenue faster over the past five years (67.47% vs 4.19% CAGR).
Metrics side by side
Valuation
| Metric | CYTK | HIMS |
|---|---|---|
| P/S ratio | 107.49 | 2.53 |
| P/B ratio | N/A | 20.12 |
| FCF yield | N/A | 1.38% |
Profitability
| Metric | CYTK | HIMS |
|---|---|---|
| Gross margin | 84.97% | 73.84% |
| Operating margin | -695.44% | 4.50% |
| Net margin | -1259.87% | -5.51% |
| ROE | N/A | -43.83% |
| ROIC | -39.80% | -4.30% |
Growth (annualized)
| Metric | CYTK | HIMS |
|---|---|---|
| Revenue CAGR (5Y) | 4.19% | 67.47% |
| Total return CAGR (5Y) | 11.24% | 32.23% |
Frequently asked
- Which has grown faster, CYTK or HIMS?
- Over the past five years, HIMS grew revenue faster — CYTK at a 4.19% CAGR versus HIMS at 67.47%.
- How have CYTK and HIMS total returns compared?
- Over the past 5 years, CYTK delivered 11.24% and HIMS delivered 32.23% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cytokinetics ROEHims & Hers Health ROECytokinetics operating marginHims & Hers Health operating marginCytokinetics revenue growthHims & Hers Health revenue growthCytokinetics free cash flowHims & Hers Health free cash flow
Cytokinetics & Hims & Hers Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.